Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019
Author(s) -
Hedvig Glans,
Leif Dotevall,
Gert Van der Auwera,
Aldert Bart,
Johannes Blum,
Pierre Buffet,
Romain Guéry,
JeanPierre Gangneux,
Saskia van Henten,
Gundel Harms,
Stefania Varani,
Florence Robert-Gangneux,
Robert Rongisch,
Björn Andersson,
Maria Bradley
Publication year - 2022
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2022.06.025
Subject(s) - leishmania tropica , cutaneous leishmaniasis , medicine , leishmaniasis , retrospective cohort study , surgery , immunology
Cutaneous leishmaniasis (CL) in Asia, Northern, and Sub-Saharan Africa is mainly caused by Leishmania major and Leishmania tropica. We describe and evaluate the treatment outcome of CL among travelers and migrants in Europe.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom